They will assess your individual circumstances, including your current glycaemic control, weight management goals, reasons for discontinuation, and overall health status
The Digital Twin for Predictive Performance is the computational engine that personalizes it for the Athlete / Patient
According to a 2024 report by Harvard Health, the Food and Drug Administration has approved a total of 10 GLP-1 medications for treating diabetes and obesity, with other applications like drug addiction still being studied
Study Links Wegovy to Possible Increased Risk of Blood Clots According to a 2021 study titled Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials, semaglutide drugs may increase a persons risk of developing a type of blood clot, called a deep vein thrombosis (DVT), by 266%
Dlaczego wybr PEN-a buduje autorytet badania